J Korean Med Sci.  2014 Nov;29(Suppl 3):S167-S169. 10.3346/jkms.2014.29.S3.S167.

Stem Cell and Research in Plastic Surgery

• Eun SC

• KMID: 2151409
• DOI: http://doi.org/10.3346/jkms.2014.29.S3.S167

Abstract

Regenerative medicine using stem cells has progressed significantly over the last decade. Plastic surgeons historically have used tissues of human being to restore various defect sites and utilized a single cell lines for the tissue regeneration. The cell sources (autologous or allogeneic), cell types (embryonic stem cell or adult stem cell), and source of tissues (bone marrow, muscle, adipose, cartilage, or blood) are very important for stem cell-based tissue coverage. Embryonic stem cells are pluripotent precursors obtained from the inner cell mass of the blastocyst and reported to be used for preventing muscle atrophy after peripheral nerve injury. Multipotent adult stem cells are easily accessed for plastic surgeons during many routine procedures. This article briefly review the current state of overall stem cell research and clinical applications in the plastic surgical field.

Keyword

Stem Cell; Plastic Surgery; Research

MeSH Terms

*Embryonic Stem Cells
Graft Rejection/prevention & control
Humans
*Induced Pluripotent Stem Cells
Reconstructive Surgical Procedures
Regenerative Medicine/*methods
Surgery, Plastic/*methods
Tissue Engineering/*methods
Wound Healing

Reference

1. You HJ, Han SK. Cell therapy for wound healing. J Korean Med Sci. 2014; 29:311–319.

2. Kim KS. Book review: advances in wound repair. Arch Plast Surg. 2013; 40:639–640.

3. Cherubino M, Rubin JP, Miljkovic N, Kelmendi-Doko A, Marra KG. Adipose-derived stem cells for wound healing applications. Ann Plast Surg. 2011; 66:210–215.

4. Choi J, Minn KW, Chang H. The efficacy and safety of platelet-rich plasma and adipose-derived stem cells: an update. Arch Plast Surg. 2012; 39:585–592.

5. Shin HS, Oh HY. The effect of platelet-rich plasma on wounds of OLETF rats using expression of matrix metalloproteinase-2 and -9 mRNA. Arch Plast Surg. 2012; 39:106–112.

6. Lorenz HP, Hedrick MH, Chang J, Mehrara BJ, Longaker MT. The impact of biomolecular medicine and tissue engineering on plastic surgery in the 21st century. Plast Reconstr Surg. 2000; 105:2467–2481.

7. Sterodimas A, De Faria J, Correa WE, Pitanguy I. Tissue engineering in plastic surgery: an up-to-date review of the current literature. Ann Plast Surg. 2009; 62:97–103.

8. Chim H, Schantz JT. Human circulating peripheral blood mononuclear cells for calvarial bone tissue engineering. Plast Reconstr Surg. 2006; 117:468–478.

9. Nussenbaum B, Teknos TN, Chepeha DB. Tissue engineering: the current status of this futuristic modality in head neck reconstruction. Curr Opin Otolaryngol Head Neck Surg. 2004; 12:311–315.

10. Lim EH, Sardinha JP, Myers S. Nanotechnology biomimetic cartilage regenerative scaffolds. Arch Plast Surg. 2014; 41:231–240.

11. McArdle A, Senarath-Yapa K, Walmsley GG, Hu M, Atashroo DA, Tevlin R, Zielins E, Gurtner GC, Wan DC, Longaker MT. The role of stem cells in aesthetic surgery: fact or fiction? Plast Reconstr Surg. 2014; 134:193–200.

12. Butala P, Hazen A, Szpalski C, Sultan SM, Coleman SR, Warren SM. Endogenous stem cell therapy enhances fat graft survival. Plast Reconstr Surg. 2012; 130:293–306.

13. Yoshimura K, Sato K, Aoi N, Kurita M, Hirohi T, Harii K. Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg. 2008; 32:48–55. discussion 6-7.

14. Lee SK, Kim DW, Dhong ES, Park SH, Yoon ES. Facial soft tissue augmentation using autologous fat mixed with stromal vascular fraction. Arch Plast Surg. 2012; 39:534–539.

15. Zhao J, Yi C, Zheng Y, Li L, Qiu X, Xia W, Su Y, Diao J, Guo S. Enhancement of fat graft survival by bone marrow-derived mesenchymal stem cell therapy. Plast Reconstr Surg. 2013; 132:1149–1157.

16. Whitaker IS, Duggan EM, Alloway RR, Brown C, McGuire S, Woodle ES, Hsiao EC, Maldonado C, Banis JC Jr, Barker JH. Composite tissue allotransplantation: a review of relevant immunological issues for plastic surgeons. J Plast Reconstr Aesthet Surg. 2008; 61:481–492.

17. Eun SC. Facial transplantation surgery. Arch Plast Surg. 2014; 41:174–180.

18. Cendales L, Hardy MA. Immunologic considerations in composite tissue transplantation: overview. Microsurgery. 2000; 20:412–419.

19. Kuo YR, Chen CC, Goto S, Lee IT, Huang CW, Tsai CC, Wang CT, Chen CL. Modulation of immune response and T-cell regulation by donor adipose-derived stem cells in a rodent hind-limb allotransplant model. Plast Reconstr Surg. 2011; 128:661e–672e.

20. Eun SC. Composite tissue allotransplantation immunology. Arch Plast Surg. 2013; 40:141–153.

21. Kuo YR, Goto S, Shih HS, Wang FS, Lin CC, Wang CT, Huang EY, Chen CL, Wei FC, Zheng XX, et al. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model. Transplantation. 2009; 87:1769–1777.

22. Burd A. Past. Present. Future? J Plast Reconstr Aesthet Surg. 2007; 60:1081.

23. West CC, Murray IR, ZN. G, Hindle P, Hay DC, Stewart KJ, Péault B. Ethical, legal and practical issues of establishing an adipose stem cell bank for research. J Plast Reconstr Aesthet Surg. 2014; 67:745–751.